Reclazepam
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Boghog (talk | contribs) at 06:38, 23 March 2022 (templated cite; marked URL as dead (cannot find a replacement)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Drug
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H13Cl2N3O2 |
Molar mass | 374.22 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Reclazepam[1] is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.[2]
See also
References
- ^ US 4208327, Yonan PK, "5-Aryl-1-(2-oxazolin-2-yl)-1H-1,4-benzodiazepines and related compounds", issued 17 June 1980, assigned to GD Searle LLC.
- ^ "Reclazepam". Pscyhotropics.dk. 20 January 1986. Retrieved 24 August 2009.
{{cite web}}
: CS1 maint: url-status (link)